Unlocking Europe's Biotech Market: Licensing, Commercialization & Market Access

Europe offers significant opportunities for U.S. biotech and pharmaceutical companies seeking licensing agreements, strategic partnerships, and commercialization pathways. Early drug-development decisions can significantly shape future European licensing opportunities, commercialization strategies, and asset value.

Join the Economic Development Partnership of North Carolina (EDPNC) and NCBiotech for a GLOBE webinar featuring experts from Switzerland and Germany. Following a brief introductory presentation, a moderated fireside chat will explore the key business considerations, strategies, and opportunities for bringing innovative therapies to Europe.

Topics to be Discussed

• Planning for Europe
• Licensing and asset value
• Navigating European markets
• Switzerland's strategic role
• Emerging policy developments
• Avoiding common pitfalls

Who Should Attend

Biotech and pharmaceutical founders, executives, and business development teams interested in European licensing, strategic partnerships, and commercialization opportunities, including companies in preclinical and clinical development.